Chemical Compound
Cholestan-3-ol, (3ss,5ss)-; 5ss-Cholestan-3ss-ol (8CI); (3ss,5ss)-Cholestan-3-ol; 3ss-Hydroxy-5ss-cholestanol; 5ss-Coprostanol; Coprostan-3-ol; Coprostan-3ss-ol; Coprostanol; Coprosterol; Koprosterin; Koprosterol; NSC 18175; NSC 5060; Stercorin
CAS Registry Number
360-68-9
Primary record
Cholestan-3-ol, (3ss,5ss)-; 5ss-Cholestan-3ss-ol (8CI); (3ss,5ss)-Cholestan-3-ol; 3ss-Hydroxy-5ss-cholestanol; 5ss-Coprostanol; Coprostan-3-ol; Coprostan-3ss-ol; Coprostanol; Coprosterol; Koprosterin; Koprosterol; NSC 18175; NSC 5060; Stercorin
- 库存
- 9,190 克
- 纯度
- 98.1 %
- CAS
- 360-68-9
化合物标识与属性
- CAS
- 360-68-9
- PubChem CID
- 221122
- SMILES
- C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@@H](C4)O)C)C
- Canonical SMILES
- CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
名称与同义词
- Coprosterol
- COPROSTANOL
- Stercorin
- Koprosterin
- Koprosterol
- Coprostan-3-ol
- 5beta-Cholestan-3beta-ol
- cholesterol
- Dihydrocholesterol
- 5beta Coprostanol
- 5beta-Cholestanol
- 5beta-Coprostanol
- beta Cholestanol
- beta-Cholestanol
- 5b-Coprostanol
- 3-beta-Cholestanol
- 5|A-coprostanol
- 360-68-9
- Cholestan 3 ol
- Cholestan-3-ol
- Coprostan-3-beta-ol
- Koprosterin [German]
- 3-beta-coprostanol
- Coprostan-3beta-ol
- 5-beta-Cholestan-3-beta-ol
- CHOLESTANOL
- 5b-Cholestan-3b-ol
- 3-beta-Hydroxycholestane
- COPROSTEROL [MI]
- RefChem:127930
- PPT67I3S74
- UNII-PPT67I3S74
- 3b-Hydroxy-5b-cholestanol
- (3b,5b)-cholestan-3-ol
- 3.BETA.-COPROSTANOL
- 3beta-Hydroxy-5beta-cholestanol
- SCHEMBL28410
- 5 beta Cholestan 3 beta ol
- 5 beta-Cholestan-3 beta-ol
- Coprostan-3-ol, >=98%
- DTXSID1052036
- CHEBI:89519
- Cholestan-3-ol,5.beta.)-
- NSC-5060
- 5 alpha Cholestan 3 beta ol
- 5 alpha-Cholestan-3 beta-ol
- 5 beta-Cholestan-3 alpha-ol
- C27H48O
- 5 alpha Cholestan 3 alpha ol
- 5 alpha-Cholestan-3 alpha-ol
- beta-Cholestan-3 beta-ol, 5
- beta-ol, 5 beta-Cholestan-3
- NSC-18175
- AC1L59T1
- orb1697734
- (3-beta,5-beta)-Cholestan-3-ol
- (3beta,5beta)-cholestan-3-ol
- Cholestan-3-ol, (3b,5b)-
- Cholestan-3-ol, (3beta,5beta)-
- 5.beta.-Cholestan-3.beta.-ol
- CHEMBL2048325
- DTXCID6030603
- CTK1C4592
- EINECS 206-638-8
- DTXSID40883258
- NSC5060
- NSC 18175
- QYIXCDOBOSTCEI-NWKZBHTNSA-N
- QYIXCDOBOSTCEI-QCYZZNICSA-N
- Koprosterin; Stercorin;NSC 5060
- AAA36068
- Cholestan-3-ol, (3beta,5alpha)-
- NSC18175
- ZINC4404494
- AR-1I2705
- C27-H48-O
- CID221122
- LMST01010078
- MFCD00068259
- 3.beta.-Hydroxy-5.beta.-cholestanol
- AKOS037645036
- Cholestan-3-ol, (3-beta,5-beta)-
- Cholestanol, (3alpha, 5beta)-Isomer
- 5-beta-Cholestan-3-Beta-Ol (Coprosterol)
- CID:221122
- J5.697I
- Cholestan-3-ol, (3.beta.,5.beta.)-
- AS-56343
- SID:53788567
- (3beta,5beta,14beta,17alpha)-cholestan-3-ol
- HY-118103
- CS-0065199
- NS00124866
- D004083
- Q5168983
- (3S,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol
- (3S,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- (1R,3aS,3bR,5aR,7S,9aS,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-hexadecahydro-1H-cyclopenta[a]phenanthren-7-ol
- (3S,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-((2R)-6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-3-ol
- (3S,5R,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- 206-638-8
- 408-16-2
- 80-97-7
- Cholestan-3-ol, (3ss,5ss)-; 5ss-Cholestan-3ss-ol (8CI); (3ss,5ss)-Cholestan-3-ol; 3ss-Hydroxy-5ss-cholestanol; 5ss-Coprostanol; Coprostan-3-ol; Coprostan-3ss-ol; Coprostanol; Coprosterol; Koprosterin; Koprosterol; NSC 18175; NSC 5060; Stercorin
- CLR
- QNJ